News-Medical.Net Urinary Tract Infection News Feed
Pioneering procedure for common prostate condition offered by The London Clinic
Mon, 24 Sep 2018 06:26:00 -0400
The London Clinic is one of the first hospitals in the UK to offer prostate artery embolization, a new procedure for non-cancerous enlargement of the prostate, a very common condition in older men.
Sun Pharma receives U.S. FDA approval for CEQUA to treat patients with dry eye disease
Thu, 16 Aug 2018 04:30:34 -0400
Sun Pharmaceutical Industries Ltd. today announced that Sun Pharma has received approval for CEQUA (cyclosporine ophthalmic solution) 0.09%, from the U.S. Food and Drug Administration. CEQUA is indicated to increase tear production in patients with keratoconjunctivitis sicca (dry eye).
FDA approves first oral medication for treatment of adults with Fabry disease
Fri, 10 Aug 2018 21:17:37 -0400
The U.S. Food and Drug Administration today approved Galafold (migalastat), the first oral medication for the treatment of adults with Fabry disease.
CNDA approves KEYTRUDA for treatment of advanced melanoma
Thu, 26 Jul 2018 09:44:18 -0400
Merck, known as MSD outside the United States and Canada, today announced that KEYTRUDA, Merck's anti-PD-1 therapy, has been approved by the China National Drug Administration for the treatment of adult patients with unresectable or metastatic melanoma following failure of one prior line of therapy.
Phase 3 study of KEYTRUDA monotherapy meets primary endpoint
Wed, 25 Jul 2018 12:11:00 -0400
Merck, known as MSD outside the United States and Canada, announced today that the pivotal Phase 3 KEYNOTE-048 trial investigating KEYTRUDA, Merck's anti-PD-1 therapy, for first-line treatment of recurrent or metastatic head and neck squamous cell carcinoma, met a primary endpoint of overall survival as monotherapy in patients whose tumors expressed PD-L1.
New guideline recommends first-trimester screening of pregnant women for asymptomatic bacteriuria
Mon, 09 Jul 2018 03:50:01 -0400
First-trimester screening of pregnant women for asymptomatic bacteriuria -- higher than normal bacteria levels without symptoms of a bladder infection -- is recommended by the Canadian Task Force on Preventive Health Care in an updated guideline in CMAJ
CMS policy had insignificant impact on reducing healthcare-associated infections
Mon, 02 Jul 2018 02:41:09 -0400
Hospitals may have avoided financial penalties by billing hospital-associated conditions as present at the time of the patient's admission, supporting prior work that showed that a Medicare policy designed to monetarily penalize hospitals for preventable complications had an insignificant impact on reducing healthcare-associated infections.
Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA
Mon, 25 Jun 2018 10:02:01 -0400
Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has accepted for standard review a new supplemental Biologics License Application for KEYTRUDA, Merck's anti-PD-1 therapy, as adjuvant therapy in the treatment of patients with resected, high-risk stage III melanoma and granted a Prescription Drug User Fee Act, or target action, date of February 16, 2019.
Study: Lenabasum has acceptable safety and tolerability in diffuse cutaneous systemic sclerosis
Mon, 18 Jun 2018 03:02:05 -0400
The results of an open label extension of a phase II study presented today at the Annual European Congress of Rheumatology, 2018, demonstrate that lenabasum continues to have acceptable safety and tolerability in diffuse cutaneous systemic sclerosis with no severe or serious adverse events.
That ‘living will’ you signed? At the ER, it could be open to interpretation.
Thu, 14 Jun 2018 05:48:10 -0400
"Don't resuscitate this patient; he has a living will," the nurse told Dr. Monica Williams-Murphy, handing her a document.

rssfeedwidget.com